Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92

Because of the potential of a new anti-staphylococcal lead compound SK-03-92 as a topical antibiotic, a patch, or an orally active drug, we sought to determine its safety profile and oral bioavailability. SK-03-92 had a high IC(50) (125 μg/mL) in vitro against several mammalian cell lines, and mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwan, William R., Kolesar, Jill M., Kabir, M. Shahjahan, Elder, Edmund J., Williams, Jeffrey B., Minerath, Rachel, Cook, James M., Witzigmann, Christopher M., Monte, Aaron, Flaherty, Tricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748848/
https://www.ncbi.nlm.nih.gov/pubmed/26877886
http://dx.doi.org/10.3390/antibiotics4040617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748848/
https://www.ncbi.nlm.nih.gov/pubmed/26877886
http://dx.doi.org/10.3390/antibiotics4040617

Ejemplares similares